Company Filing History:
Years Active: 2018
Title: Yi-San Tsai: Innovator in Antibody Development
Introduction
Yi-San Tsai is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies that target specific receptors involved in various diseases.
Latest Patents
Yi-San Tsai holds a patent for an "Anti-VEGFR antibody and uses thereof." This invention relates to an antibody or antigen-binding fragment that binds to the human vascular endothelial growth factor receptor 2 (VEGFR-2). The patent outlines methods for inhibiting VEGFR-2-mediated signaling in subjects, treating diseases related to VEGFR-2 activity, and detecting human vascular endothelial growth factor receptors in samples. He has 1 patent to his name.
Career Highlights
Yi-San Tsai is associated with the Development Center for Biotechnology, where he has been instrumental in advancing research and development in the field of biotechnology. His work focuses on innovative solutions for treating diseases linked to vascular endothelial growth factor signaling.
Collaborations
He has collaborated with notable colleagues, including Jiann-Shiun Lai and Li-Shuang Ai, contributing to various projects aimed at enhancing therapeutic strategies in biotechnology.
Conclusion
Yi-San Tsai's work in developing targeted antibodies showcases his commitment to advancing medical science and improving treatment options for patients. His innovative contributions continue to impact the field of biotechnology positively.